TERT and hepatocellular carcinoma: Moreover, we analyzed the follow-up outcome data from the 45 patients in the tissue microarray and 12 other HCC patients (Fig. 6A, B), and found that the HCC patients (n = 57) with high expression of NCOA3(16/57) or TERT (12/57) had poor prognosis (Fig. 6G, H), and the patients with high expression of both NCOA3 and TERT(6/57) had the worst outcomes, whereas the patients with low expression of both NCOA3 and TERT (35/57) had the best outcomes (Fig. 6I).